Joshua Schwieterman, Sekhu Ansari, Mohammad Azam. "Selective degradation of oncogenic signaling nodes by momelotinib-based protacs exerts potent anti-leukemic response in B-ALL, AML, and MF while sparing normal cells." Blood, 2025. doi:10.1182/blood-2025-6108